Krystal Biotech
KRYS----
Krystal Biotech (KRYS)
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Krystal Biotech Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$376.757.09%
Forecast & RatingStrong buy
11analysts
- Strong buy90.91%
- Buy0.00%
- Hold9.09%
- Sell0.00%
- Strong sell0.00%
News
- Unusual Whales · Jul 23 at 04:02 PM
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
- PUBT · Jul 23 at 04:01 PM
Krystal Biotech updates financial calendar with quarterly results release, conference call
- Simplywall · Jul 23 at 12:07 AM
Is A Single-Patient KB801 Outcome Quietly Reframing Krystal Biotech's Clinical Narrative (KRYS)?
- TradingView · Jul 21 at 04:33 PM
Krystal Biotech files patent response citing single-patient KB801 corneal closure
- StockTitan · Jul 20 at 08:42 AM
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600 | BRK Stock News
- Simplywall · Jul 14 at 08:16 PM
Is Krystal Biotech (KRYS) Too Expensive After A 440% Return?
